May 23, 2025

Sage Therapeutics, Inc. (SAGE) Stock Analysis: Exploring the 24% Potential Upside in Biotech

Sage Therapeutics, Inc. (NASDAQ: SAGE) offers a compelling opportunity for investors within the biotechnology sector, particularly those interested in the development and commercialization of brain health medicines. With a market..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: A Biotech with Over 440% Potential Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a promising player in the biotechnology sector, is capturing investor attention with its ambitious gene therapy programs targeting rare and life-threatening diseases. Headquartered in Cranbury,..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Navigating Growth in Pediatric Orthopedics with a 72% Upside Potential

OrthoPediatrics Corp. (NASDAQ: KIDS), a key player in the healthcare sector, is making strides in the specialized field of pediatric orthopedic medical devices. As a company dedicated to developing anatomically..

CeriBell, Inc. (CBLL) Stock Report: Harnessing a Potential 79.61% Upside in the Medical Devices Sector

CeriBell, Inc. (CBLL), a burgeoning player in the healthcare sector, is capturing investor attention with its innovative approach to neurological diagnostics. Based in Sunnyvale, California, this medical technology company is..

Replimune Group, Inc. (REPL) Stock Analysis: An Insight into a Biotech Gem with 141% Upside Potential

Investors with a keen interest in the biotechnology sector will find Replimune Group, Inc. (NASDAQ: REPL) a compelling opportunity. This clinical-stage biotech company is at the forefront of developing oncolytic..

Pharming Group N.V. (PHAR) Stock Analysis: Unveiling a Potential 188.89% Upside for Investors

Pharming Group N.V. (PHAR), a Netherlands-based biopharmaceutical firm, is capturing investor attention with its promising growth trajectory and strategic collaborations aimed at addressing rare diseases. With a market capitalization of..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Challenges with a 22% Upside Potential

AMN Healthcare Services Inc (NYSE: AMN) has positioned itself as a key player in the healthcare staffing and solutions industry, specializing in providing technology-driven workforce solutions to healthcare facilities across..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: A Biotech with 153% Potential Upside

Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a burgeoning player in the biotechnology sector, stands out with a significant potential upside of 153.38%, according to the latest analyst ratings. For investors keen..

Inventiva S.A. (IVA) Stock Analysis: Exploring a 247% Potential Upside in the Biotech Sector

Inventiva S.A. (NASDAQ: IVA), a clinical-stage biopharmaceutical company based in France, is capturing investor attention with its promising drug development pipeline and significant potential upside. Specializing in oral small molecule..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Unveiling a Potential 347.63% Upside

Anavex Life Sciences Corp. (NASDAQ: AVXL), a clinical-stage biopharmaceutical company based in New York, has captured the attention of investors with its promising drug pipeline targeting central nervous system diseases...

Altimmune, Inc. (ALT) Stock Analysis: Exploring a Potential 256% Upside in the Biotech Sector

Altimmune, Inc. (NASDAQ: ALT) is a clinical-stage biopharmaceutical company that has caught the eye of investors with its ambitious pipeline and notable potential upside. With a market capitalization of $467.99..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Is a 214% Upside Within Reach for This Biotech Innovator?

Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology company, has captured the attention of investors with an eye-catching potential upside of 214.32%. Specializing in precision medicines targeting fibroblast growth factor..

Sonida Senior Living, Inc. (SNDA): An Investor Outlook on Revenue Growth and Potential Upside

Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector, operates within the medical care facilities industry, focusing on providing senior housing and related services across the United..

Taysha Gene Therapies (TSHA) Investor Outlook: Exploring a Promising 147% Upside Potential

As Taysha Gene Therapies, Inc. (TSHA) navigates the complex landscape of biotechnology, investors are keenly eyeing its potential for significant growth. With a market capitalization of $611.79 million, this Dallas-based,..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring a 433% Potential Upside in Biotech

For investors looking to capitalize on the biotech sector’s potential, Upstream Bio, Inc. (NASDAQ: UPB) stands out as a compelling opportunity. With a remarkable 433.48% potential upside, as indicated by..

Verastem, Inc. (VSTM): A Biotech Stock with Over 110% Potential Upside According to Analyst Ratings

Verastem, Inc. (NASDAQ: VSTM), a development-stage biopharmaceutical company, stands out in the biotechnology sector with its promising pipeline focused on cancer treatment. With a market capitalization of $411.02 million, Verastem..

Definitive Healthcare Corp. (DH) Stock Analysis: Is a 30.99% Upside Worth the Risk?

Definitive Healthcare Corp. (NASDAQ: DH) presents a compelling opportunity for investors intrigued by the intersection of healthcare and technology. Specializing in healthcare commercial intelligence, Definitive Healthcare offers a software-as-a-service (SaaS)..

Tilray Brands, Inc. (TLRY) Investor Outlook: Exploring a Potential 189.62% Upside

Tilray Brands, Inc. (NASDAQ: TLRY), a leading lifestyle consumer products company in the healthcare sector, has sparked significant interest among investors due to the potential upside of 189.62%. With a..

Embecta Corp. (EMBC) Stock Analysis: Exploring a 73.73% Potential Upside in Healthcare Innovation

In the dynamic world of healthcare investments, Embecta Corp. (NASDAQ: EMBC) presents a compelling case for investors seeking opportunities in the medical instruments and supplies sector. As a company with..

COMPASS Pathways Plc (CMPS) Investor Outlook: Exploring a Potential 313% Upside in the Mental Health Revolution

As the healthcare sector continues to evolve, COMPASS Pathways Plc (NASDAQ: CMPS) stands at the forefront of pioneering mental health solutions. With a focus on innovative psilocybin therapy, the company’s..

Search

Funds

May 23, 2025

Search

Funds

May 23, 2025

FTSE 100

Funds